Acetylsalicylic acid Enrolling by Invitation Phase 2 Trials for Acute Respiratory Distress Syndrome (ARDS) Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02326350ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial